openPR Logo
Press release

Tardive Dyskinesia Therapeutics Market to Witness Impressive Expansion of USD 5.57 Billion By 2032

03-27-2024 07:46 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Tardive Dyskinesia Therapeutics Market

Tardive Dyskinesia Therapeutics Market

Polaris Market Research analyzes that the Tardive Dyskinesia Therapeutics Market is anticipated to witness steady growth, reaching USD 5.57 billion by 2032. The market was valued at USD 3.83 billion in 2023 and is projected to grow at a CAGR of 4.3% during the forecast period of 2024 to 2032.

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž! https://www.polarismarketresearch.com/industry-analysis/tardive-dyskinesia-therapeutics-market/request-for-sample

Tardive Dyskinesia is a movement condition affecting the nervous system of the body. It's caused by prolonged use of neuroleptic drugs, which are used in the treatment of psychiatric conditions. The most common symptoms of tardive dyskinesia involve involuntary movements of the tongue and the mouth. Along with that, it may also affect the legs, arms, trunks, and respiratory muscles of the body. Less commonly, it may affect prominent body parts like the neck. Tardive dyskinesia therapeutics is concerned with the treatment of the condition.

The first-line management of tardive dyskinesia involves discontinuing or stopping the drugs that may be causing the involuntary movements. The most commonly used medications for treating the condition include deuterabenazine and valbenazine. In some cases, deep brain stimulation or botulinum toxin may help. With the rising prevalence of the condition and increased emphasis on tardive dyskinesia therapeutics market key players on gaining product approvals, the industry is projected to witness steady growth. Besides, the implementation of favorable policies by government agencies worldwide is anticipated to impact the industry favorably.

๐‹๐ž๐š๐๐ข๐ง๐  ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ

โ€ข Allergan
โ€ข Contera Pharma
โ€ข Johnson & Johnson Services Inc.
โ€ข Lannett Co. Inc.
โ€ข Luye Pharma Group
โ€ข Mitsubishi Tanabe Pharma Corporation
โ€ข Neurocrine Biosciences Inc.
โ€ข Prestwick Pharmaceuticals Inc.
โ€ข Reddy Laboratories Ltd.
โ€ข SOM Biotech
โ€ข SteriMax Inc.
โ€ข Sun Pharmaceutical Industries Ltd.
โ€ข Teva Pharmaceutical Industries Ltd.
โ€ข Valeant Pharmaceuticals

๐†๐ž๐ญ ๐€๐ก๐ž๐š๐ ๐ฐ๐ข๐ญ๐ก ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.polarismarketresearch.com/buy/3662/2

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ฒ๐ง๐š๐ฆ๐ข๐œ๐ฌ:

โ€ข ๐‘๐ข๐ฌ๐ข๐ง๐  ๐€๐ฐ๐š๐ซ๐ž๐ง๐ž๐ฌ๐ฌ ๐š๐ง๐ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ข๐ฌ: Increasing awareness of tardive dyskinesia among healthcare professionals and patients is expected to drive early diagnosis and treatment initiation, thereby expanding the market.

โ€ข ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐„๐ง๐ฏ๐ข๐ซ๐จ๐ง๐ฆ๐ž๐ง๐ญ: Regulatory agencies' approval of new treatments and expanded indications for existing therapies can significantly impact market growth and competition.

โ€ข ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐จ๐ง: The Tardive Dyskinesia Therapeutics Market is characterized by intense competition among pharmaceutical companies striving to develop safer, more efficacious treatments with improved tolerability profiles.

๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐š๐ง๐ ๐‚๐ก๐š๐ฅ๐ฅ๐ž๐ง๐ ๐ž๐ฌ ๐ˆ๐ง ๐“๐š๐ซ๐๐ข๐ฏ๐ž ๐ƒ๐ฒ๐ฌ๐ค๐ข๐ง๐ž๐ฌ๐ข๐š ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

โ€ข ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง: There is a significant opportunity for pharmaceutical companies and biotechnology firms to innovate and develop novel therapies targeting specific pathways implicated in tardive dyskinesia pathophysiology.

โ€ข ๐๐š๐ญ๐ข๐ž๐ง๐ญ-๐‚๐ž๐ง๐ญ๐ซ๐ข๐œ ๐€๐ฉ๐ฉ๐ซ๐จ๐š๐œ๐ก: Tailoring treatment regimens to individual patient needs preferences can enhance treatment adherence and outcomes.

โ€ข ๐‚๐ก๐š๐ฅ๐ฅ๐ž๐ง๐ ๐ž๐ฌ ๐ข๐ง ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ: Conducting clinical trials for tardive dyskinesia and therapeutics poses challenges due to the heterogeneity of the patient population, ethical considerations, and the need for long-term safety data.

๐๐จ๐ฐ ๐ญ๐จ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ-๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง, ๐”๐ง๐œ๐จ๐ฏ๐ž๐ซ ๐Š๐ž๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ, ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ, ๐š๐ง๐ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค! https://www.polarismarketresearch.com/industry-analysis/tardive-dyskinesia-therapeutics-market

๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‡๐š๐ฌ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐“๐ก๐ž ๐“๐š๐ซ๐๐ข๐ฏ๐ž ๐ƒ๐ฒ๐ฌ๐ค๐ข๐ง๐ž๐ฌ๐ข๐š ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐š๐ฌ๐ž๐ ๐Ž๐ง ๐ƒ๐ซ๐ฎ๐ , ๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐“๐ฒ๐ฉ๐ž, ๐€๐ง๐ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ:

๐“๐š๐ซ๐๐ข๐ฏ๐ž ๐ƒ๐ฒ๐ฌ๐ค๐ข๐ง๐ž๐ฌ๐ข๐š ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ, ๐ƒ๐ซ๐ฎ๐  ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)

โ€ข Deutetrabenazine
โ€ข Valbenazine
โ€ข Others

๐“๐š๐ซ๐๐ข๐ฏ๐ž ๐ƒ๐ฒ๐ฌ๐ค๐ข๐ง๐ž๐ฌ๐ข๐š ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ, ๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐“๐ฒ๐ฉ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)
โ€ข Solid Dosage Forms
โ€ข Tablets
โ€ข Capsules
โ€ข Liquid Dosage Form
โ€ข Injection

๐“๐š๐ซ๐๐ข๐ฏ๐ž ๐ƒ๐ฒ๐ฌ๐ค๐ข๐ง๐ž๐ฌ๐ข๐š ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ, ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž - ๐”๐’๐ƒ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ— - ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)

โ€ข Hospital Pharmacies
โ€ข Drug Stores & Retail Pharmacies
โ€ข Online Pharmacies
โ€ข Others

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐…๐จ๐ซ ๐…๐ฎ๐ซ๐ญ๐ก๐ž๐ซ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

๐‹๐š๐ฌ๐ž๐ซ ๐‚๐š๐ฉ๐ญ๐ฎ๐ซ๐ž ๐Œ๐ข๐œ๐ซ๐จ๐๐ข๐ฌ๐ฌ๐ž๐œ๐ญ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.linkedin.com/pulse/laser-capture-microdissection-market-surge-worth-usd-39774-valdes-c6k3f

๐†๐ž๐ง๐ž ๐„๐ฑ๐ฉ๐ซ๐ž๐ฌ๐ฌ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.linkedin.com/pulse/gene-expression-analysis-market-projected-achieve-usd-alice-valdes-omtyf

๐‚๐ž๐ง๐ญ๐ซ๐š๐ฅ ๐‹๐š๐› ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.linkedin.com/pulse/central-lab-market-poised-63-cagr-envisioned-value-vq15f

๐Œ๐ข๐œ๐ซ๐จ๐œ๐š๐ญ๐ก๐ž๐ญ๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.linkedin.com/pulse/microcatheter-market-set-reach-usd-134247-j4aif

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ˆ๐ง๐Ÿ๐จ:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tardive Dyskinesia Therapeutics Market to Witness Impressive Expansion of USD 5.57 Billion By 2032 here

News-ID: 3443374 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
07-14-2025 | Consumer Goods & Retail
Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
07-14-2025 | Health & Medicine
Polaris Market Research & Consulting
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
07-14-2025 | Chemicals & Materials
Polaris Market Research & Consulting
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
07-14-2025 | Health & Medicine
Polaris Market Research & Consulting
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for Pharma

09-16-2024 | Advertising, Media Consulting, โ€ฆ
Market Research Intellect
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโ€ฆ
07-22-2024 | Advertising, Media Consulting, โ€ฆ
Market Research Intellect
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
07-18-2024 | Advertising, Media Consulting, โ€ฆ
Market Research Intellect
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
06-21-2024 | Business, Economy, Finances, B โ€ฆ
ABNewswire
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
02-22-2022 | Health & Medicine
INFINITY BUSINESS INSIGHTS
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ
05-13-2020 | Health & Medicine
Business Industry Reports
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โ€ฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโ€ฆ